Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Total Debt (2017 - 2026)

Bioceres Crop Solutions' Total Debt history spans 10 years, with the latest figure at $54.1 million for Q1 2026.

  • On a quarterly basis, Total Debt fell 28.53% to $54.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $54.1 million, a 28.53% decrease, with the full-year FY2025 number at $163.4 million, down 8.63% from a year prior.
  • Total Debt hit $54.1 million in Q1 2026 for Bioceres Crop Solutions, down from $163.4 million in the prior quarter.
  • Over the last five years, Total Debt for BIOX hit a ceiling of $178.9 million in Q2 2024 and a floor of $54.1 million in Q1 2026.
  • Historically, Total Debt has averaged $131.0 million across 5 years, with a median of $154.5 million in 2022.
  • Biggest five-year swings in Total Debt: increased 16.59% in 2022 and later fell 28.53% in 2026.
  • Tracing BIOX's Total Debt over 5 years: stood at $145.5 million in 2022, then grew by 15.69% to $168.3 million in 2023, then grew by 6.26% to $178.9 million in 2024, then dropped by 8.63% to $163.4 million in 2025, then tumbled by 66.9% to $54.1 million in 2026.
  • Business Quant data shows Total Debt for BIOX at $54.1 million in Q1 2026, $163.4 million in Q2 2025, and $75.7 million in Q1 2025.